What is the recommended dose of parenteral amoxicillin for an adult, and how should it be adjusted in renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Parenteral Amoxicillin Dosing in Adults

Standard intravenous amoxicillin dosing for adults is 1000 mg every 6 hours (4 g/day total), but current dose reductions recommended for renal impairment may lead to subtherapeutic concentrations and should be avoided for less susceptible pathogens. 1

Standard Dosing Regimen

  • The typical IV dose is 1000 mg administered every 6 hours for hospitalized adults with normal renal function, providing adequate coverage for most susceptible organisms 1
  • The first dose should be administered in a supervised clinical setting with resuscitation equipment readily available 2
  • Infusion should occur over 15-20 minutes to minimize adverse reactions 2

Renal Impairment Adjustments: Critical Reconsideration

Traditional dose reduction strategies may be inadequate:

  • Recent pharmacometric modeling demonstrates that recommended dose reductions result in clinically relevant reduction in probability of target attainment, particularly for pathogens with MIC ≥8 mg/L 1
  • For patients with CKD-EPI of 10-30 mL/min/1.73 m², standard dose reductions achieve only 38-92% probability of target attainment versus 100% with standard dosing 1
  • Amoxicillin clearance correlates strongly with body weight and CKD-EPI, allowing more precise individualized dosing 1

Traditional Dosing Adjustments (Use with Caution)

  • Creatinine clearance >30 mL/min: No adjustment needed; use standard 1000 mg every 6 hours 3, 4
  • Creatinine clearance 10-30 mL/min: Historically recommended 500-1000 mg every 8-12 hours, but this may be insufficient for MIC >2 mg/L 3, 4
  • Creatinine clearance <10 mL/min (anephric): Expected half-life extends to 16 hours; traditional recommendation is 500 mg every 24 hours 3

Hemodialysis Patients

  • Amoxicillin half-life during hemodialysis is 2.3-3.6 hours (versus 16 hours in anephric patients off dialysis) 3, 4
  • Administer supplemental dose after each dialysis session to replace drug removed during the procedure 3, 4
  • Loading dose should be based on patient weight, with maintenance doses adjusted for residual renal function 3

Critical Dosing Principles

The key principle is maintaining adequate peak concentrations while extending dosing intervals, rather than reducing individual doses 1

  • For pathogens with MIC ≤2 mg/L, both reduced and standard doses achieve >90% probability of target attainment in renal impairment 1
  • For less susceptible organisms (MIC 4-8 mg/L), standard dosing should be maintained despite renal impairment to ensure therapeutic concentrations 1
  • The pharmacokinetic target is maintaining concentrations above MIC for 40% of the dosing interval 1

Safety Considerations

  • High-dose amoxicillin (>300 mg/kg/day) carries risk of crystalluria and tubular obstruction, requiring adequate hydration and urine alkalinization 5
  • Maximum daily dose should not exceed 6 g in adults without specific infectious disease consultation 5
  • Monitor for hypersensitivity reactions, particularly during initial supervised administration 2

Common Pitfalls to Avoid

  • Do not reduce individual dose size in renal impairment—this creates subtherapeutic peak concentrations; instead, extend the dosing interval 1, 3
  • Do not rely solely on serum creatinine in elderly patients; calculate CKD-EPI or corrected creatinine clearance accounting for body weight 1, 3
  • Do not forget supplemental dosing after hemodialysis, as significant drug removal occurs during dialysis 3, 4
  • Verify pathogen MIC when available—traditional dose reductions may be adequate for highly susceptible organisms but insufficient for borderline susceptibility 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.

International journal of clinical pharmacology, therapy, and toxicology, 1982

Research

[Acute renal failure with high-dose combination therapy with penicillin G and amoxicillin].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.